The prognosis of disseminated intravascular coagulation associated with hematologic malignancy and its response to recombinant human thrombomodulin-Reference-Cited by-同舟云学术

The prognosis of disseminated intravascular coagulation associated with hematologic malignancy and its response to recombinant human thrombomodulin

Published:2019-01 Issue: Volume:173 Page:57-64
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Kurita Naoki^ORCID,Sakamoto Tatsuhiro,Kato Takayasu,Kusakabe Manabu,Yokoyama Yasuhisa^ORCID,Nishikii Hidekazu,Sakata-Yanagimoto Mamiko,Obara Naoshi,Hasegawa Yuichi,Chiba Shigeru

Publisher

Elsevier BV

Subject

Hematology

Reference38 articles.

1. Disseminated intravascular coagulation in acute leukemia: clinical and laboratory features at presentation;Yanada;Eur. J. Haematol.,2006

2. YB-1 is important for an early stage embryonic development: neural tube formation and cell proliferation;Uchiumi;J. Biol. Chem.,2006

3. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia;Chang;Eur. J. Haematol.,2012

4. Classifying types of disseminated intravascular coagulation: clinical and animal models;Asakura;J. Intensive Care,2014

5. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation—a comparison with other anticoagulants;Mohri;Thromb. Haemost.,1999

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies;International Journal of Hematology;2024-01-25

2. Disseminated intravascular coagulation for paediatricians: the whats, whys and hows;Paediatrics and Child Health;2022-11

3. The pathogenesis and the treatment strategy of DIC complicated with hematological malignancy;Japanese Journal of Thrombosis and Hemostasis;2022